^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p
Primary hepatic schwannoma mimicking malignancy on fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography–computed tomography
✍ Scribed by Young Chul Kim; Mi-Suk Park
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 414 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The authors conducted a comprehensive review of the efficacy of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography (FDG‐PET) in the detection of primary tumors in patients with disseminated carcinoma of unknown primary site. ## METHODS. Ten studies (involvin
## Abstract ## BACKGROUND The clinical value of positron emission tomography (PET) with [^18^F]fluoro‐2‐deoxy‐D‐glucose (FDG) for primary staging in cervical carcinoma appears to be promising. The authors sought to evaluate the diagnostic efficacy and benefit of PET in restaging cervical carcinoma
## BACKGROUND. Positron emission tomography (PET) with 2-deoxy-2-fluoro[ 18 F]-Dglucose (FDG) can provide quantitative information about tumor glucose metabolism. The prognostic value of this technique was evaluated for breast carcinoma patients. ## METHODS. FDG PET was performed on 70 patients w